News and updates
BENIGN HEMATOLOGY in 2023 and beyond

The term "benign hematology" has traditionally been used to refer to non-malignant blood disorders.
Wiley and European Hematology Association Announce Partnership

Hoboken, NJ, (USA) and The Hague (Netherlands), June 9, 2023.
Wiley, one of the world’s largest publishers and a global leader in research and education, today announced that it will publish the open access journal HemaSphere on behalf of the European Hematology Association (EHA), the largest community of European hematologists, beginning in January 2024.
More than science: the European Affairs program at EHA2023

The ‘EU & Hematology track’ and other European Affairs activities at EHA2023 shed light on important regulatory developments and offer a platform for dialogue between hematologists, patients and other stakeholders.
In Memoriam Professor Emeritus Michel Symann

Dear Colleagues, My dear friend Professor Emeritus Michel Symann passed away on April 23, 2023 at the age of 81.
EHA-EMN Joint Session at the European Myeloma Network Meeting EMN2023

On Saturday, 22 April, EHA and EMN brought together patients, regulators and clinicians to discuss Novel Endpoints in Multiple Myeloma.
Nikolai Klimko 1956-2023

Professor Nikolai Klimko Professor Nikolai Klimko, MD PhD, FECMM March 22, 1956 - March 30, 2023 With deepest sorrow we learned that on March 30, 2023, Professor Nikolai Nikolaevich Klimko passed at age…
In Memoriam Jean Claude Brouet

Professor Jean Claude Brouet passed away on December 12, 2022 at the age of 80.
EHA launches Global Hematology Professionals’ Survey

The Hague (Netherlands), March 27, 2023. In unpredictable times, it's more important than ever that the European Hematology Association has a greater impact in harmonizing education, supporting career development and research, connecting hematologists worldwide, and advocating for the profession.
Immunoglobulin shortages in the spotlight: EMA, SUPPLY and the SoHO Regulation

EMA executive director Emer Cooke welcoming participants including EHA at the Shortages Workshop, March 1 Shortages of immunoglobulins and the need to increase and sustain plasma supplies have moved to the…
New HemaSphere publication on IVDR implementation

The In Vitro Diagnostic medical devices Regulation (IVDR), which came in to force in May 2022 with the objective of safeguarding the quality and safety of diagnostic tests in the EU,…
EHA Statement: Our sustained solidarity with the hematology community in Ukraine

Friday, February 24 marks one year of war. The European Hematology Association (EHA) stands in solidarity with our colleagues and friends in Ukraine.
Moldova to be allowed to participate in EU4Health projects

The European Commission and the Government of the Republic of Moldova have signed an agreement to associate Moldova with the EU4Health program.
EHA Statement of Solidarity with local communities in Türkiye and Syria

The European Hematology Association (EHA) is deeply concerned about the situation in southern Türkiye and northern Syria: Monday's earthquakes and aftershocks have killed thousands of people and destroyed innumerable buildings,…
Ukraine Bridge Funding - information for applicants

The EHA Ukraine Bridge Funding Program is a 1-year non-clinical funding opportunity for Ukrainian hematologists and researchers in hematology (see press release here), now in collaboration with the American Society…